 |
| CrossRef Text and Data Mining |
| Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. |
| Treatment of acute tacrolimus toxicity with phenytoin after Paxlovid (nirmatrelvir/ritonavir) administration in a kidney transplant recipient |
| Eun-Jeong Kwon, Gi-Ae Yun, Seokwoo Park, Sejoong Kim, Dong-Wan Chae, Hyung Sub Park, Taeseung Lee, Jong Cheol Jeong |
|
Kidney Res Clin Pract. 2022;41(6):768-770. Published online November 29, 2022 DOI: https://doi.org/10.23876/j.krcp.22.218 |
|
Treatment of acute tacrolimus toxicity with phenytoin after Paxlovid (nirmatrelvir/ritonavir) administration in a kidney transplant recipient Kidney Research and Clinical Practice. 2022;41(6):768-770  Elevated tacrolimus levels after treatment with nirmatrelvir/ritonavir (Paxlovid) for COVID-19 infection in a child with a kidney transplant Pediatric Nephrology. 2022; Tacrolimus Drug–Drug Interaction with Nirmatrelvir/Ritonavir (Paxlovid™) Managed with Phenytoin Journal of Medical Toxicology. 2022;19(1):45-48 Nirmatrelvir+ritonavir/tacrolimus interaction Reactions Weekly. 2022;1914(1):355-355 Nirmatrelvir+ritonavir/tacrolimus Reactions Weekly. 2022;1925(1):405-405 Nirmatrelvir+ritonavir/tacrolimus interaction Reactions Weekly. 2022;1936(1):386-386 Nirmatrelvir+ritonavir/tacrolimus interaction Reactions Weekly. 2022;1931(1):465-465 Paxlovid (Nirmatelvir/Ritonavir) and Tacrolimus Drug-Drug Interaction in a Kidney Transplant Patient with SARS-2-CoV infection: A Case Report Transplantation Proceedings. 2022;54(6):1557-1560 Single‐center experience with nirmatrelvir/ritonavir in kidney transplant recipients on tacrolimus maintenance immunosuppression Clinical Transplantation. 2022;36(8): Nirmatrelvir+ritonavir/tacrolimus/tozinameran Reactions Weekly. 2022;1918(1):388-388 |
